Virginia to receive payments from new opioid settlement

A multi-state settlement with opioid manufacturer Amneal Pharmaceuticals could total .5 million in cash payments and 0 million in naloxone nasal spray to combat opioid overdoses. The agreement announced May 6 in principle would resolve claims that Amneal failed to monitor and report suspicious orders placed by its customers, as it was required by federal law, according to the office of Virginia Attorney General Jason Miyares, who was among the group of six attorneys general who negotiated the settlement. “The prescription opioid crisis wreaked havoc across Virginia,” Miyares said. “By holding opioid manufacturers accountable for their role in the epidemic,...

Article Link